Khalil Mallah, Kazem Zibara, Coline Kerbaj, Ali Eid, Nour Khoshman, Zahraa Ousseily, Abir Kobeissy, Tristan Cardon, Dasa Cizkova, Firas Kobeissy, Isabelle Fournier & Michel Salzet. (2021) Neurotrauma investigation through spatial omics guided by mass spectrometry imaging: Target identification and clinical applications. Mass Spectrometry Reviews 42:1, pages 189-205.
Crossref
Shawn G. Rhind, Gary Wynn, Eric Vermetten & Rakesh Jetly. (2020) Biomarkers for military mental health: Insights, challenges, and future prospects. Journal of Military, Veteran and Family Health 6:S1, pages 51-67.
Crossref
Jonathan Fine, Rachel Lackner, Ram Samudrala & Gaurav Chopra. (2019) Computational chemoproteomics to understand the role of selected psychoactives in treating mental health indications. Scientific Reports 9:1.
Crossref
Mai Taha, Yasmeen M. Taalab, Warda F. Abo-Elez & Sahar A. Eldakroory. (2019) Cannabis and Tramadol are Prevalent among the First Episode Drug-Induced Psychosis in the Egyptian Population: Single Center Experience. Reports 2:2, pages 16.
Crossref
Subramanyam Busetty. 2019. Handbook of Environmental Materials Management. Handbook of Environmental Materials Management
1367
1397
.
Ihsan Cetin & Omer F. Demirel. (2018) Increased serum levels of spectrin degradation products in patients with schizophrenia. Turkish Journal of Biochemistry 43:1, pages 22-29.
Crossref
Subramanyam Busetty. 2018. Handbook of Environmental Materials Management. Handbook of Environmental Materials Management
1
31
.
George Anis Sarkis, Manasi D. Mangaonkar, Ahmed Moghieb, Brian Lelling, Michael Guertin, Hamad Yadikar, Zhihui Yang, Firas Kobeissy & Kevin K. W. Wang. (2017) The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries. Current Neurology and Neuroscience Reports 17:3.
Crossref
Atlal El-Assaad, Zaher Dawy, Georges Nemer & Firas Kobeissy. (2017) Novel Bioinformatics–Based Approach for Proteomic Biomarkers Prediction of Calpain-2 & Caspase-3 Protease Fragmentation: Application to βII-Spectrin Protein. Scientific Reports 7:1.
Crossref
Hadi Abou-El-Hassan, Fares Sukhon, Edwyn Jeremy Assaf, Hisham Bahmad, Hussein Abou-Abbass, Hussam Jourdi & Firas H. Kobeissy. 2017. Neuroproteomics. Neuroproteomics
65
99
.
Atlal El-Assaad, Zaher Dawy, Georges Nemer, Hazem Hajj & Firas H. Kobeissy. 2017. Neuroproteomics. Neuroproteomics
329
352
.
Naify Ramadan, Hussein Ghazale, Mohammad El-Sayyad, Mohamad El-Haress & Firas H. Kobeissy. 2017. Neuroproteomics. Neuroproteomics
3
19
.
Ahmed Moghieb, Helen M. Bramlett, Jyotirmoy H. Das, Zhihui Yang, Tyler Selig, Richard A. Yost, Michael S. Wang, W. Dalton Dietrich & Kevin K.W. Wang. (2016) Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury. Molecular & Cellular Proteomics 15:7, pages 2379-2395.
Crossref
Rui Zhu, Tianjiao Yang, Firas Kobeissy, Tarek H. Mouhieddine, Mohamad Raad, Amaly Nokkari, Mark S. Gold, Kevin K. Wang & Yehia Mechref. (2016) The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats. PLOS ONE 11:4, pages e0151034.
Crossref
MAHDI RAZAFSHA, AUNALI KHAKU, HASSAN AZARI, ALI ALAWIEH, HURA BEHFORUZI, BILAL FADLALLAH, FIRAS H. KOBEISSY, KEVIN K. WANG & MARK S. GOLD. (2015) Biomarker Identification in Psychiatric Disorders. Journal of Psychiatric Practice 21:1, pages 37-48.
Crossref
Firas H. KobeissyBasri GulbakanAli AlawiehPierre KaramZhiqun ZhangJoy D. Guingab-CagmatStefania MondelloWeihong TanJohn AnagliKevin Wang. (2014) Post-Genomics Nanotechnology Is Gaining Momentum: Nanoproteomics and Applications in Life Sciences. OMICS: A Journal of Integrative Biology 18:2, pages 111-131.
Crossref
MingMing Ning, Mary Lopez, Jing Cao, Ferdinando S. Buonanno & Eng H. Lo. (2012) Application of proteomics to cerebrovascular disease. ELECTROPHORESIS 33:24, pages 3582-3597.
Crossref
Matthias J. Müller. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
523
531
.
Torsten Klengel & Elisabeth B Binder. (2011) Using gene–environment interactions to target personalized treatment in mood disorder. Personalized Medicine 8:1, pages 23-34.
Crossref
Jerson Laks & Eliasz Engelhardt. (2010) Peculiarities of Geriatric Psychiatry: A Focus on Aging and Depression. CNS Neuroscience & Therapeutics 16:6, pages 374-379.
Crossref
Richard A. Greer & Mark S. Gold. 2010. Principles of Addictions and the Law. Principles of Addictions and the Law
177
192
.
Zhiqun Zhang, Stephen F. Larner, Firas Kobeissy, Ronald L. Hayes & Kevin K. W. Wang. 2010. Systems Biology in Drug Discovery and Development. Systems Biology in Drug Discovery and Development
317
329
.
Firas H. Kobeissy, Shankar Sadasivan, Melinda Buchanan, Zhiqun Zhang, Mark S. Gold & Kevin K. W. Wang. 2010. Systems Biology in Drug Discovery and Development. Systems Biology in Drug Discovery and Development
303
316
.
Marie-Pierre Moisan & André Ramos. 2010. Rat Genomics. Rat Genomics
357
388
.
Jack F. Samuels. (2009) Recent advances in the genetics of obsessive-compulsive disorder. Current Psychiatry Reports 11:4, pages 277-282.
Crossref
Manuel B. Graeber. (2009) Biomarkers for Parkinson's disease. Experimental Neurology 216:2, pages 249-253.
Crossref
Firas H. Kobeissy, Zhiqun Zhang, Shankar Sadasivan, Mark S. Gold & Kevin K. W. Wang. 2009. Neuroproteomics. Neuroproteomics
217
228
.
Andrew K. Ottens. 2009. Neuroproteomics. Neuroproteomics
1
21
.
Michael S. Ritsner & Irving I. Gottesman. 2009. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
3
21
.